This dual mechanism triggers a self-reinforcing therapeutic cycle: ferroptosis releases tumor antigens, activating CD8+ T cells to secrete interferon-γ (IFN-γ), which suppresses GPX4 expression and exacerbates lipid peroxidation, thereby sustaining ferroptotic cell death. The gene discussed is GPX4; the disease is neoplasm.